Back to Search
Start Over
Topiramate-Responsive Tremor in a Novel Pathogenic Variant of SPG15 Patient
- Source :
- Clinical Neuropharmacology. 43:121-122
- Publication Year :
- 2020
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2020.
-
Abstract
- Hereditary spastic paraplegia (HSP) is group of a rare neurodegenerative disorder with both genetically and clinically diverse neurologic features. Indeed, disease progression is varying greatly within the different forms and current treatment modalities are exclusively symptomatic for HSP. Tremor in HSP patients is only mentioned with rare case reports, so treatment option is lack in clinical ground. We reported a case of a HSP-15 girl with a previously reported novel mutation of SPG15 complained of a life disturbing tremor and topiramate as a drug therapy for tremor in our HSP patient.
- Subjects :
- Topiramate
Pediatrics
medicine.medical_specialty
Hereditary spastic paraplegia
03 medical and health sciences
0302 clinical medicine
Pharmacotherapy
Tremor
Rare case
Humans
Medicine
Pharmacology (medical)
Child
Pharmacology
Spastic Paraplegia, Hereditary
business.industry
Disease progression
Genetic Variation
Treatment options
medicine.disease
nervous system diseases
030227 psychiatry
Treatment modality
Anticonvulsants
Female
Neurology (clinical)
Carrier Proteins
business
Novel mutation
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- ISSN :
- 1537162X and 03625664
- Volume :
- 43
- Database :
- OpenAIRE
- Journal :
- Clinical Neuropharmacology
- Accession number :
- edsair.doi.dedup.....d5d79f6fc347a535bed164aa85ec31f4
- Full Text :
- https://doi.org/10.1097/wnf.0000000000000392